
HOME HOT LEGAL ISSUES Accidents Automotive Defective Products Drugs/Medical Elder Care Employment Environment Financial Food/Supplements Insurance Malpractice Personal Injury Securities NEWS ARTICLES Accidents Antitrust Automotive Bankruptcy Business Civil/Human Rights Criminal Law Defective Products Discrimination Drugs/Medical DUI Elder Care Employment Environment Family Law Financial Food/Supplements Immigration Insurance Intellectual Property Internet/Technology Malpractice Media/Telecom Personal Injury Real Estate Securities Stock Fraud Whistleblower Wills/Trusts/Estates Workers Compensation EMERGING ISSUES Accidents Antitrust Automotive Bankruptcy Business Civil/Human Rights Criminal Law Defective Products Discrimination Drugs/Medical Elder Care Employment Environment Family Law Financial Food/Supplements Immigration Insurance Intellectual Property Internet/Technology Malpractice Media/Telecom Personal Injury Real Estate Securities Whistleblower Workers Compensation LAWSUITS FILED Accidents Antitrust Automotive Bankruptcy Business Civil/Human Rights Consumer Banking Consumer Fraud Defective Products Discrimination Drugs/Medical Elder Care Employment Environment Family Law Financial Food/Supplements Immigration Insurance Intellectual Property Internet/Technology Malpractice Media/Telecom Personal Injury Real Estate Securities SETTLEMENTS Accidents Antitrust Automotive Bankruptcy Business Civil/Human Rights Criminal Law Defective Products Discrimination Drugs/Medical DUI Elder Care Employment Employment Law Environment Family Law Financial Food/Supplements Immigration Insurance Intellectual Property Internet/Technology Malpractice Media/Telecom Personal Injury Real Estate Securities Whistleblower Wills/Trusts/Estates Workers Compensation STATE LAW Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Alberta British Columbia Manitoba Newfoundland New Brunswick Nova Scotia Northwest Territories Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon BLOG
What are you looking for?

AstraZeneca PLC

Seroquel

A class action lawsuit has been filed against AstraZeneca PLC on behalf of all patients who have used the anti-psychotic drug Seroquel. The suit was filed in regards to a study which was recently released and linked the use of Seroquel to an unacceptable rate of diabetes onset. The suit alleges that the company was aware that use of Seroquel could cause a high occurrence of diabetes; however they failed to adequately warn doctors or patients in the United States. The suit further claims that although the versions of Seroquel sold in Japan are accompanied with a warning label, this safer, more accurate and comprehensive label has not been used in the US. The suit also alleges that AstraZeneca engaged in marketing and promoting Seroquel for off label use that was beyond its FDA approved indications.

If you feel you qualify for damages or remedies that might be awarded in this class action please click the link below to submit your complaint.

Please click here for a free evaluation of your case

Last updated on Sep-2-03